InnoCan Pharma (FRA:IP4) 1-Year Share Buyback Ratio : -3.80% (As of Mar. 2025 )

View and export this data going back to 2020. Start your Free Trial

What is InnoCan Pharma 1-Year Share Buyback Ratio?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

1-Year Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past year, calculated as the percentage change in shares outstanding from the previous year to the current year. A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance. InnoCan Pharma's current 1-Year Share Buyback Ratio was -3.80%.

FRA:IP4's 1-Year Share Buyback Ratio is ranked worse than
60.58% of 515 companies
in the Drug Manufacturers industry
Industry Median: -1.1 vs FRA:IP4: -3.80

Competitive Comparison of InnoCan Pharma's 1-Year Share Buyback Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, InnoCan Pharma's 1-Year Share Buyback Ratio, along with its competitors' market caps and 1-Year Share Buyback Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

InnoCan Pharma's 1-Year Share Buyback Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, InnoCan Pharma's 1-Year Share Buyback Ratio distribution charts can be found below:

* The bar in red indicates where InnoCan Pharma's 1-Year Share Buyback Ratio falls into.

Save Embed

;

Save Embed

;

InnoCan Pharma 1-Year Share Buyback Ratio Calculation

InnoCan Pharma's 1-Year Share Buyback Ratio for the quarter that ended in Mar. 2025 is calculated as

1-Year Share Buyback Ratio	=	(Shares Outstanding (EOP) (Mar. 2024 )	-	Shares Outstanding (EOP) (Mar. 2025 ))	/	Shares Outstanding (EOP) (Mar. 2024 )
	=	(280.661	-	291.227)	/	280.661
	=	-3.8%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

InnoCan Pharma (FRA:IP4) 1-Year Share Buyback Ratio Explanation

A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance.

Be Aware

Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.

InnoCan Pharma 1-Year Share Buyback Ratio Related Terms

InnoCan Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » InnoCan Pharma Corp (FRA:IP4) » Definitions » 1-Year Share Buyback Ratio

Comparable Companies

Traded in Other Exchanges

INNPF:USA INNO:Canada

Address

1015, 926 - 5 Avenue SW, Calgary, AB, CAN, T2P 0N7

Website

https://www.innocanpharma.com

InnoCan Pharma Corp is a pharmaceutical tech company that focuses on the development of several drug delivery platforms combining cannabidiol with other pharmaceutical ingredients as well as the development and sale of CBD-integrated pharmaceuticals. Geographically, it derives a majority of its revenue from the United States.

InnoCan Pharma Headlines

No Headlines